U.S. markets closed

Stereotaxis, Inc. (STXS)

NYSE American - NYSE American Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
2.6100+0.1000 (+3.98%)
Al cierre: 04:00PM EDT
2.6300 +0.02 (+0.77%)
Fuera de horario: 05:37PM EDT

Stereotaxis, Inc.

710 North Tucker Boulevard
Suite 110
Saint Louis, MO 63101
United States
314 678 6100
https://www.stereotaxis.com

Sector(es)Healthcare
IndustriaMedical Instruments & Supplies
Empleados a tiempo completo122

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.CEO & Chairman62.2kN/D1987
Ms. Kimberly R. PeeryCFO & Secretary251.84kN/D1969
Mr. Keith GallowayVice President of OperationsN/DN/DN/D
Ms. Laura Spencer GarthGeneral Counsel & SecretaryN/DN/DN/D
Mr. Guy JudkowskiEquity Portfolio ManagerN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Gestión corporativa

La calificación ISS Governance QuickScore de Stereotaxis, Inc. a partir del 1 de marzo de 2024 es 8. Las puntuaciones principales son Auditoría: 8; Junta: 8; Derechos del accionista: 9; Compensación: 8.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.